New Delhi: Indian drug regulators have taken action against 105 pharmaceutical companies after a risk-based inspection and audit of manufacturing plants, the Health Minister Mansukh Mandaviya said on Tuesday.
The action by national and state regulators comes after Indian-made cough syrups were linked to the deaths of dozens of children overseas. The minister said production has been stopped at 31 companies while product licence cancellations or suspensions have been issued against a further 50 companies.
India’s pharmaceutical industry is one of the biggest in the world but its reputation was shaken after the World Health Organization (WHO) found toxins in cough syrups made by three Indian companies.
Comments